2012至2023年系统性红斑狼疮发病率、死亡率与并发症的人群队列研究
基于英格兰临床实践研究数据链的人群队列研究纳入2012至2023年4937例新诊断成人SLE患者,按4:1匹配对照。SLE发病率在所有族裔中呈下降趋势,但患者全因死亡风险显著高于对照(HR 2.06;95%CI:1.84,2.32),除实体癌外所有研究并发症风险均升高。黑人族裔SLE发病率最高,且较白人SLE患者死亡及部分并发症风险更高。
要点
- SLE患者全因死亡风险约为对照的2倍(HR 2.06;95%CI:1.84,2.32)。
- 除实体癌外,SLE患者所有研究并发症风险均显著升高。
- 黑人加勒比裔2023年发病率最高(11.07/10万人年;95%CI:6.05,18.58)。
核心结论
- 尽管SLE发病率下降,患者死亡率仍为对照的2倍,且存在族裔间不平等。
- 黑人族裔SLE患者较白人患者死亡及糖尿病、血栓、心肌炎/心包炎和间质性肺病风险更高。
研究设计与样本
- 基于英格兰临床实践研究数据链的人群队列研究,纳入2012至2023年新诊断成人SLE患者,对照按4:1匹配年龄、性别和初级保健诊所。
- 采用灵活参数模型和竞争风险模型分别估计死亡与并发症风险。
主要发现
- SLE发病率在研究期间所有族裔中均下降。
- SLE患者死亡风险显著高于对照(HR 2.06;95%CI:1.84,2.32)。
- 黑人加勒比裔2023年发病率最高(11.07/10万人年;95%CI:6.05,18.58)。
- 黑人SLE患者较白人SLE患者死亡风险更高(HR 1.64;95%CI:1.05,2.55),且糖尿病、血栓、心肌炎/心包炎和间质性肺病风险增加。
关键数值与推荐
- SLE患者较对照死亡HR 2.06(95%CI:1.84,2.32)。
- 黑人SLE患者较白人SLE患者死亡HR 1.64(95%CI:1.05,2.55)。
- 2023年黑人加勒比裔SLE发病率11.07/10万人年(95%CI:6.05,18.58)。
临床怎么用
- 临床应关注SLE患者整体死亡风险升高,尤其黑人族裔患者的死亡及代谢、血栓、心肺并发症风险。
- 对黑人族裔SLE患者可加强糖尿病、血栓、心肌炎/心包炎和间质性肺病的筛查与监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Ethnicity-related inequalities in the epidemiology of systemic lupus erythematosus (SLE) have been consistently described, yet robust population-level data remain limited. We aimed to characterize the incidence, all-cause mortality and complications of SLE in a contemporary, ethnically diverse, nationwide cohort. METHODS: We conducted a population-level study using the Clinical Practice Research Datalink in England. Individuals aged ≥18 years with new SLE diagnoses between 2012 and 2023 were included. Controls were selected in a 4:1 ratio and matched on age, sex and primary care practice. Risk of death and complications were estimated using flexible parametric and competing-risk models, respectively. RESULTS: The cohort consisted of 4937 incident SLE diagnoses (87.9% female; median age 47 years). The incidence of SLE declined over the study period across all ethnicities. Compared with controls (n = 19 707), patients with SLE had significantly higher mortality risk [hazard ratio (HR) 2.06; 95% CI: 1.84, 2.32] and elevated risk of all studied complications except solid cancers. SLE incidence was highest among people of Black ethnic background, with the greatest rates observed in Black Caribbean individuals (11.07 per 100 000 person-years in 2023; 95% CI: 6.05, 18.58). Compared with White individuals with SLE, Black individuals had significantly higher mortality (HR 1.64; 95% CI: 1.05, 2.55) and increased risks of diabetes, thrombosis, myocarditis/pericarditis and interstitial lung disease. CONCLUSION: Despite declining incidence, mortality for people with SLE was twice that of controls in this large contemporaneous incident cohort. Ethnicity-based inequalities were observed, with elevated mortality and morbidity risk in Black ethnic groups with SLE compared with White ethnic groups.
引用
- Patel S, Russell MD, Bechman K, et al. The incidence, mortality and complications of systemic lupus erythematosus: a population-level cohort study from 2012 to 2023. Rheumatology (Oxford). 2026. PMID: 42001214. doi:10.1093/rheumatology/keag206
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。